Oxford Biodynamics launches prostate screening test
EpiSwitch is designed for men with prostate cancer risk in the UK and is 94% accurate
Read More
Tag: Prostate
Men with enlarged prostates offered robotic treatment by fourth University Hospital
Aquablation is a robotic method that uses a high-pressure saline solution to remove tissue
Read More
Astellas and Pfizer reveal positive results for Xtandi
Research data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer
Read More
New device launched for diagnosing prostate cancer
CamPROBE may save vital time and money while reducing the risk of infection
Read More
Stada launches prostate cancer treatment across 21 European countries
Company is introducing abiraterone film-coated tablets for treating metastatic prostate cancer
Read More
Nubeqa success in Phase III prostate cancer study
“A positive trend in overall survival” had been seen in a trial, with an interim analysis demonstrating a 29% reduction in the risk of death for Nubeqa.
Read More
Parsortix test could avoid unnecessary prostate biopsies
Currently, investigation of symptoms for prostate cancer is typically made via an invasive blood test.
Read More
‘World’s most accurate blood test’ for prostate cancer launched in UK
The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention.
Read More
NICE backs procedure for benign prostate enlargement
The National Institute for Health and Care Excellence is now endorsing a procedure called Prostate Artery Embolisation (PAE) for NHS use to treat benign prostatic hyperplasia.
Read More
Laser surgery for BPH could save NHS £3.2m
NICE is supporting use of Boston Scientific’s laser therapy GreenLight XPS to treat benign prostatic hyperplasia, which could improve outcomes for patients and save the NHS a substantial chunk of cash.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
